Targeting Th17 cells in autoimmune diseases
- 1 October 2014
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 35 (10), 493-500
- https://doi.org/10.1016/j.tips.2014.07.006
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- A Validated Regulatory Network for Th17 Cell SpecificationCell, 2012
- Targeting IL-17 and TH17 cells in chronic inflammationNature Reviews Drug Discovery, 2012
- Targeting IL-17 and Th17 Cells in Rheumatoid ArthritisRheumatic Disease Clinics of North America, 2010
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndromeNature, 2008
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T CellsImmunity, 2006
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationThe Journal of Experimental Medicine, 2005
- Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitisNature Medicine, 2002